Subpart G—Tumor Associated Antigen immunological Test Systems

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 866
8. ›
9. Subpart G

Sections

Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.

• 866.6000
  § 866.6000 Whole exome sequencing constituent device.
• 866.6010
  § 866.6010 Tumor-associated antigen immunological test system.
• 866.6020
  § 866.6020 Immunomagnetic circulating cancer cell selection and enumeration system.
• 866.6030
  § 866.6030 AFP-L3% immunological test system.
• 866.6040
  § 866.6040 Gene expression profiling test system for breast cancer prognosis.
• 866.6050
  § 866.6050 Ovarian adnexal mass assessment score test system.
• 866.6060
  § 866.6060 BCR-ABL quantitation test.
• 866.6070
  § 866.6070 Mutation detection test for myeloproliferative neoplasms.
• 866.6080
  § 866.6080 Next generation sequencing based tumor profiling test.
• 866.6090
  § 866.6090 Cancer predisposition risk assessment system.
• 866.6100
  § 866.6100 DNA-based test to measure minimal residual disease in hematological malignancies.